K-RAS antibody (N-Term)
Quick Overview for K-RAS antibody (N-Term) (ABIN634246)
Target
See all K-RAS (KRAS) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- KRAS antibody was raised against the N terminal of KRAS
-
Purification
- Affinity purified
-
Immunogen
- KRAS antibody was raised using the N terminal of KRAS corresponding to a region with amino acids TEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETC
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
KRAS Blocking Peptide, (ABIN5614396), is also available for use as a blocking control in assays to test for specificity of this KRAS antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KRAS antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- K-RAS (KRAS) (GTPase Kras (KRAS))
-
Alternative Name
- KRAS
-
Background
- KRAS is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma.
-
Molecular Weight
- 22 kDa (MW of target protein)
Target
-